Journal Mobile Options
Table of Contents
Vol. 44, No. 1, 2000
Issue release date: July 2000
Eur Neurol 2000;44:42–44
(DOI:10.1159/000008191)

Transient Ischemic Attack in Heavy Cannabis Smokers – How ‘Safe’ Is It?

Mouzak A. · Agathos P. · Kerezoudi E. · Mantas A. · Vourdeli-Yiannakoura E.
To view the fulltext, log in and/or choose pay-per-view option

Individual Users: Register with Karger Login Information

Please create your User ID & Password





Contact Information











I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in

Abstract

Drugs are lately considered high-risk factors for cerebrovascular disease. Three male patients (mean age 24.6 years) who were heavy cannabis smokers presented with transient ischemic attacks (TIA) shortly after cannabis abuse. The complete examination of all 3 consisted of: EEG, brain CT scan, brain MRI, cerebral vessel angiography (digital subtraction and magnetic resonance angiography); also a full cerebrospinal fluid, urine and blood analysis (immunological, biochemical and hormonal tests were included). Urine was further examined for drug metabolites. An extensive cardiological investigation was carried out. Small vessel leukoencephalopathy was revealed by the brain CT and MRI. EEG recordings of the first patient showed paroxysmal sharp waves with left hemispheric dominance. The other 2 patients had diffuse delta and theta activity in their EEG tracings. The urine analysis was positive for cannabis metabolites. There were no other abnormal findings in the rest of the meticulous and thorough study of all 3 patients, which leads to the conclusion that cannabis was the only risk factor responsible for the observed TIA, contradictory to other studies, which support that cannabis is a ‘safe’ drug. More research is required in order for this issue to be completely elucidated.

Copyright © 2000 S. Karger AG, Basel



Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

References

  1. Sloan MA, Kittner SJ, Rigamonti D, Price TR: Occurence of stroke associated with use/abuse of drugs. Neurology 1991;41:1358–1364.
  2. Zachariah SB: Stroke after heavy marijuana smoking. Stroke 1991;22:406–409.
  3. Cooles P: Stroke after heavy cannabis smoking (letter). Postgrad Med 1987;63:511.
  4. Hollister L: Healthy aspects of cannabis. Pharmacol Rev 1986;38:1–20.
  5. Hollister L: Cannabis. Acta Psychiatr Scand 1988;78:108–118.
  6. Kaku D, Lowenstein DH: Emergence of recreational drug abuse as a major risk factor for strike in young adults. Ann Intern Med 1990;113:821–827.
  7. Brust J: Clinical, radiological, and pathological aspects of cerebrovascular disease associated with drug abuse. Stroke 1993;24(suppl I):129–133.
  8. Barnes D, Palace J, O`Briein MD: Stroke following marijuana smoking. Stroke 1992;23:1381.
  9. Lawson TM, Rees A: Stroke and transient ischaemic attack in association with substance abuse in a young man. Postgrad Med J 1996; 72:692–693.

    External Resources

  10. Brust JCM: Vasculitis owing to substance abuse. Neurol Clin 1997;15:945–957.
  11. Spadone C: Neurophysiologie du cannabis. Encephale 1991;17:17–22.
  12. Mathew RJ, Wilson WH, Tant SR: Acute changes in cerebral blood flow associated with marijuana smoking. Acta Psychiatr Scand 1989;79:118–128.

    External Resources

  13. Mathew RJ, Wilson WH: Substance abuse and cerebral blood flow. Am J Psychiatry 1991;148:292–305.
  14. Brust JCM: Drug dependence; in Joynt RJ (ed): Clinical Neurology, revised. Philadelphia, Lippincott, vol 2, chap 21, pp 36–41.
  15. Celius GE, Andersson S: Leucoencephalopathy after inhalation of heroin: A case report. J Neurol Neurosurg Psychiatry 1996;60:694–695.
  16. Weber W, Henkes H, Moller P, Bade K, Kühne D: Toxic spongiform leucoencephalopathy after inhaling heroin vapor. Eur Radiol 1998;85:749–755.

    External Resources

  17. Sempere AP, Dosada I, Ramo C, Cabello A: Spongiform leucoencephalopathy after inhaling heroin. Lancet 1991;338:320.
  18. Wolters EC, van Wijngaarden GK, Stam FC, Rengelink H, Lousberg RJ, Schipper ME, Verbeeten B: Leucoencephalopathy after inhaling ‘heroin’ pyrosylate. Lancet 1982;ii:1233–1237.
  19. Sloan MA, Kittner SJ, Levine SR: Recreational drug use and stroke. Ann Intern Med 1991;114:605.
  20. Martin PJ, Enevoldson TP, Humphrey PRD: Causes of ischaemic stroke in the young. Postgrad Med J 1997;73:8–16.


Pay-per-View Options
Direct payment This item at the regular price: USD 33.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 23.00